Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
July 19th, 2018
15.2K views
This article shows the method for the surgical placement in mice of an intraperitoneal catheter attached to an access port that is positioned at the back of the animal. Moreover, it explains the procedure for a 5/6 nephrectomy to resemble the uremic state of PD patients.
Overview
This article demonstrates a surgical method for placing an intraperitoneal catheter in mice, which is essential for studying peritoneal dialysis. It also details a 5/6 nephrectomy procedure to mimic the uremic state in patients.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Peritoneal Dialysis Research
Background
- The method allows for the study of peritoneal and systemic alterations in response to fluid exposure.
- It is particularly useful under both uremic and non-uremic conditions.
- Large volumes of fluid can be injected over extended periods.
- Genetically modified animals can be utilized for deeper insights into molecular mechanisms.
Purpose of Study
- To facilitate research into peritoneal deterioration and its implications for therapy.
- To enable testing of therapeutic strategies and biomarker evaluations.
- To explore molecular cues involved in peritoneal damage using genetically modified mice.
Methods Used
- Surgical placement of an intraperitoneal catheter in mice.
- 5/6 nephrectomy procedure to induce uremic conditions.
- Disinfection of the surgical site using 1% chlorhexidine gluconate.
- Monitoring of animal response during the procedure.
Main Results
- The technique allows for significant fluid injection capacity.
- Facilitates long-term treatment and observation of mice.
- Enables the use of genetically modified mice for advanced research.
- Provides insights into the structural and functional aspects of peritoneal health.
Conclusions
- This method is a valuable tool in peritoneal dialysis research.
- It opens avenues for therapeutic and diagnostic advancements.
- Future studies can leverage this technique to better understand peritoneal damage.
Frequently Asked Questions
What is the significance of using genetically modified mice?
Genetically modified mice allow researchers to study specific molecular pathways involved in peritoneal damage.
How does the catheter placement procedure work?
The procedure involves shaving the animal, disinfecting the area, and carefully placing the catheter to ensure proper function.
What are the advantages of this surgical method?
It allows for large fluid volumes to be injected and supports long-term studies in a controlled environment.
What conditions can this method simulate?
It can simulate both uremic and non-uremic conditions, providing a comprehensive understanding of peritoneal responses.
What are the implications for therapy?
The technique may lead to improved therapeutic strategies and better diagnostic tools for peritoneal health.
How does this research contribute to the field of peritoneal dialysis?
It enhances the understanding of peritoneal deterioration and potential interventions to mitigate damage.
Executive Industry Relevance
This surgical model enables preclinical evaluation of peritoneal dialysis interventions by providing a reproducible system for long-term fluid exposure and uremic condition modeling. It supports target validation and mechanistic de-risking in peritoneal fibrosis and inflammation pathways using genetically modified mice. The technique facilitates biomarker evaluation and therapeutic strategy testing relevant to renal replacement therapy development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to peritoneal damage mechanisms under controlled uremic conditions.
- Operational Value: Supports functional target validation through longitudinal assessment of structural and functional peritoneal alterations.
- Predictive Value: Enhances predictive confidence by modeling chronic peritoneal deterioration observed in clinical peritoneal dialysis.
Screening & Assay Development
- Scientific Value: Provides a disease-relevant system for preparing validated biological systems to assess compound effects on peritoneal integrity.
- Operational Value: Enables assay standardization through consistent surgical preparation and fluid infusion protocols.
- Scalability: Supports platform reuse across multiple study arms due to rapid procedure completion (5-7 minutes for catheter placement).
Translational & Preclinical Research
- Translational Continuity: Mimics the state of renal insufficiency in peritoneal dialysis patients via 5/6 nephrectomy-induced uremia.
- Mechanistic De-risking: Allows evaluation of molecular cues in peritoneal damage using genetically modified models.
- Risk-Adjusted Advancement: Supports go/no-go decisions by quantifying peritoneal thickness, cell recruitment, and biomarker changes over time.
Pipeline & Workflow Integration
The method integrates into discovery biology and preclinical workflows by enabling hypothesis testing, pathway clarification, and quantitative assessment of peritoneal responses to therapeutic interventions.
- Discovery Biology: Supports hypothesis testing of molecular pathways involved in peritoneal fibrosis and inflammation.
- Screening: Enables assay readiness for evaluating compounds aimed at preserving peritoneal function during dialysis.
- Analytics: Generates quantitative dependent variable measurements including peritoneal thickness, cell recruitment, and serum urea nitrogen levels.
- Translational Research: Connects to preclinical validation through uremic state modeling and longitudinal peritoneal deterioration tracking.
- Enterprise Reuse: Represents a reusable surgical capability for chronic peritoneal dialysis studies across multiple therapeutic programs.
Operational & Enterprise Impact
- Scientific Value: Reduction of mechanistic ambiguity in peritoneal damage pathways through controlled, long-term fluid exposure models.
- Operational Value: Standardization and reproducibility of catheter placement and nephrectomy procedures across genetically diverse mouse models.
- Strategic Value: Improved go/no-go decisions by enabling early detection of peritoneal deterioration signals.
- Portfolio Impact: Risk-adjusted prioritization of peritoneal protective therapies based on quantifiable fibrosis and inflammation endpoints.
Implementation Considerations
- Requires expertise in murine surgical techniques including vessel ligation and tissue handling.
- Dependent on sterile surgical instrumentation and access to cauterization and suturing tools.
- Necessitates cross-team standardization of postoperative monitoring and fluid infusion protocols.
- Adaptation considerations include variations in mouse strain, sex, and genetic background affecting peritoneal response.
- Practical limitations include surgical mortality risk and variability in catheter patency over extended infusion periods.
Biopharma FAQs
Why is 5/6 nephrectomy performed in this model?
The 5/6 nephrectomy procedure induces a uremic state that mimics renal insufficiency in peritoneal dialysis patients, enabling study of peritoneal damage under clinically relevant conditions.
How does catheter placement enable long-term peritoneal dialysis studies?
Surgical placement of the catheter with subcutaneous access port allows repeated intraperitoneal infusion of large fluid volumes over extended periods without repeated peritoneal puncture, reducing infection and inflammation.
What quantitative measurements are used to assess peritoneal damage?
Peritoneal thickness and cell recruitment in tissues distant from the catheter are measured to quantify structural alterations, which are exacerbated in nephrectomized animals during dialysis.
Why are replication requirements important for cross-functional collaboration?
Standardized surgical procedures ensure reproducible model generation across laboratories, enabling consistent data comparison between discovery, preclinical, and translational teams evaluating peritoneal interventions.
What statistical analysis capabilities are required before implementing this model?
Teams must be able to analyze longitudinal biomarker data such as serum urea nitrogen levels and histological metrics to determine significant differences between experimental and control groups over time.
